B-Cellular_component	0	12	Mitochondria	Mitochondrion	NNS	B-NP
O	13	15	in	in	IN	B-PP
B-Cell	16	23	Cardiac	Cardiac	JJ	B-NP
I-Cell	24	31	Myocyte	Myocyte	NN	I-NP
O	32	41	Apoptosis	Apoptosis	NN	I-NP

O	42	44	It	It	PRP	B-NP
O	45	48	has	have	VBZ	B-VP
O	49	53	been	be	VBN	I-VP
O	54	63	suggested	suggest	VBN	I-VP
O	64	68	that	that	IN	B-SBAR
O	69	79	activation	activation	NN	B-NP
O	80	82	of	of	IN	B-PP
O	83	86	the	the	DT	B-NP
B-Cellular_component	87	100	mitochondrial	mitochondrial	JJ	I-NP
O	101	110	apoptotic	apoptotic	JJ	I-NP
O	111	118	pathway	pathway	NN	I-NP
O	119	126	leading	lead	VBG	B-VP
O	127	129	to	to	TO	I-VP
O	130	141	executioner	executioner	VB	I-VP
O	142	146	casp	casp	NN	B-NP
O	147	157	activation	activation	NN	I-NP
O	158	160	is	be	VBZ	B-VP
O	161	169	relevant	relevant	JJ	B-ADJP
O	170	172	in	in	IN	B-PP
B-Organ	173	178	heart	heart	NN	B-NP
O	179	185	injury	injury	NN	I-NP
O	185	186	.	.	.	O
O	186	187	1	1	CD	B-NP
O	188	191	The	The	DT	B-NP
O	192	198	notion	notion	NN	I-NP
O	199	201	of	of	IN	B-PP
O	202	215	participation	participation	NN	B-NP
O	216	218	of	of	IN	B-PP
O	219	223	casp	casp	NN	B-NP
O	224	234	activation	activation	NN	I-NP
O	235	237	in	in	IN	B-PP
B-Cell	238	243	adult	adult	JJ	B-NP
I-Cell	244	251	cardiac	cardiac	JJ	I-NP
I-Cell	252	259	myocyte	myocyte	NN	I-NP
O	260	269	apoptosis	apoptosis	NN	I-NP
O	270	277	emerged	emerge	VBD	B-VP
O	278	282	from	from	IN	B-PP
O	283	290	studies	study	NNS	B-NP
O	291	296	using	use	VBG	B-VP
O	297	315	immunofluorescence	immunofluorescence	NN	B-NP
O	316	328	microscopy16	microscopy16	NN	I-NP
O	329	332	and	and	CC	I-NP
O	333	337	casp	casp	NN	I-NP
O	338	348	inhibitors	inhibitor	NNS	I-NP
O	348	349	.	.	.	O
O	349	351	37	37	CD	B-NP
O	352	356	Bahi	Bahi	NNP	I-NP
O	357	359	et	et	FW	I-NP
O	360	362	al	al	FW	I-NP
O	362	363	.	.	.	B-NP
O	363	365	38	38	CD	I-NP
O	366	378	demonstrated	demonstrate	VBD	B-VP
O	379	383	that	that	IN	B-SBAR
B-Cell	384	397	cardiomyocyte	cardiomyocyte	NN	B-NP
O	398	404	levels	level	NNS	I-NP
O	405	407	of	of	IN	B-PP
O	408	411	all	all	DT	B-NP
O	412	417	casps	casp	NNS	I-NP
O	418	426	decrease	decrease	VBP	B-VP
O	427	431	with	with	IN	B-PP
O	432	435	age	age	NN	B-NP
O	435	436	,	,	,	O
O	437	440	and	and	CC	O
O	441	445	they	they	PRP	B-NP
O	446	449	are	be	VBP	B-VP
O	450	454	very	very	RB	B-ADJP
O	455	458	low	low	JJ	I-ADJP
O	459	461	in	in	IN	B-PP
B-Cell	462	467	adult	adult	JJ	B-NP
I-Cell	468	475	cardiac	cardiac	JJ	I-NP
I-Cell	476	481	cells	cell	NNS	I-NP
O	481	482	.	.	.	O

O	483	491	Recently	Recently	RB	B-ADVP
O	491	492	,	,	,	O
O	493	496	Bae	Bae	NNP	B-NP
O	497	499	et	et	FW	I-NP
O	500	502	al	al	FW	I-NP
O	502	503	.	.	.	I-NP
O	503	505	39	39	CD	I-NP
O	506	514	reported	report	VBD	B-VP
O	515	519	that	that	IN	B-SBAR
O	520	529	apoptosis	apoptosis	NN	B-NP
O	530	533	can	can	MD	B-VP
O	534	536	be	be	VB	I-VP
O	537	544	induced	induce	VBN	I-VP
O	545	547	in	in	IN	B-PP
O	548	551	the	the	DT	B-NP
B-Organ	552	557	heart	heart	NN	I-NP
O	558	565	lacking	lack	VBG	B-VP
O	566	570	casp	casp	NN	B-NP
O	571	581	activation	activation	NN	I-NP
O	582	585	via	via	IN	B-PP
O	586	590	casp	casp	NN	B-NP
O	590	591	-	-	HYPH	B-NP
O	591	602	independent	independent	JJ	I-NP
O	603	611	pathways	pathway	NNS	I-NP
O	611	612	,	,	,	O
O	613	621	probably	probably	RB	B-ADVP
O	622	629	through	through	IN	B-PP
O	630	639	apoptosis	apoptosis	NN	B-NP
O	639	640	-	-	HYPH	O
O	640	648	inducing	induce	VBG	B-VP
O	649	655	factor	factor	NN	B-NP
O	656	657	(	(	(	O
O	657	660	AIF	AIF	NN	B-NP
O	660	661	)	)	)	O
O	661	662	.	.	.	O

O	663	667	Both	Both	CC	O
O	668	671	the	the	DT	B-NP
O	672	681	intrinsic	intrinsic	JJ	I-NP
O	682	685	and	and	CC	I-NP
O	686	695	extrinsic	extrinsic	JJ	I-NP
O	696	704	pathways	pathway	NNS	I-NP
O	705	708	can	can	MD	B-VP
O	709	711	be	be	VB	I-VP
O	712	721	inhibited	inhibit	VBN	I-VP
O	722	724	by	by	IN	B-PP
O	725	728	the	the	DT	B-NP
O	729	743	cytoprotective	cytoprotective	JJ	I-NP
O	744	751	protein	protein	NN	I-NP
O	752	761	apoptosis	apoptosis	NN	I-NP
O	762	771	repressor	repressor	NN	I-NP
O	772	776	with	with	IN	B-PP
O	777	784	caspase	caspase	NN	B-NP
O	785	796	recruitment	recruitment	NN	I-NP
O	797	803	domain	domain	NN	I-NP
O	804	805	(	(	(	O
O	805	808	ARC	ARC	NN	B-NP
O	808	809	)	)	)	O
O	809	810	.	.	.	O

O	811	814	ARC	ARC	NN	B-NP
O	815	823	inhibits	inhibit	VBZ	B-VP
O	824	827	the	the	DT	B-NP
O	828	837	extrinsic	extrinsic	JJ	I-NP
O	838	845	pathway	pathway	NN	I-NP
O	846	848	by	by	IN	B-PP
O	849	860	interacting	interact	VBG	B-VP
O	861	865	with	with	IN	B-PP
O	866	870	casp	casp	NN	B-NP
O	871	872	8	8	CD	I-NP
O	873	876	and	and	CC	O
O	877	887	components	component	NNS	B-NP
O	888	890	of	of	IN	B-PP
O	891	894	the	the	DT	B-NP
O	895	900	death	death	NN	I-NP
O	900	901	-	-	HYPH	O
O	901	909	inducing	induce	VBG	B-VP
O	910	919	signaling	signaling	NN	B-NP
O	920	927	complex	complex	NN	I-NP
O	927	928	,	,	,	O
O	929	933	such	such	JJ	B-PP
O	934	936	as	as	IN	I-PP
O	937	941	FADD	FADD	NN	B-NP
O	941	942	,	,	,	O
O	943	950	whereas	whereas	IN	O
O	951	961	inhibition	inhibition	NN	B-NP
O	962	964	of	of	IN	B-PP
O	965	968	the	the	DT	B-NP
O	969	978	intrinsic	intrinsic	JJ	I-NP
O	979	986	pathway	pathway	NN	I-NP
O	987	989	is	be	VBZ	B-VP
O	990	998	mediated	mediate	VBN	I-VP
O	999	1001	by	by	IN	B-PP
O	1002	1010	blocking	block	VBG	B-VP
O	1011	1014	BAX	BAX	NN	B-NP
O	1015	1025	activation	activation	NN	I-NP
O	1026	1029	and	and	CC	O
B-Cellular_component	1030	1042	mitochondria	mitochondrion	NNS	B-NP
O	1043	1056	translocation	translocation	NN	I-NP
O	1056	1057	.	.	.	I-NP
O	1057	1059	40	40	CD	I-NP

O	1060	1063	AIF	AIF	NN	B-NP
O	1064	1066	is	be	VBZ	B-VP
O	1067	1075	anchored	anchor	VBN	I-VP
O	1076	1078	by	by	IN	B-PP
O	1079	1082	its	its	PRP$	B-NP
O	1083	1084	N	N	NN	I-NP
O	1085	1093	terminus	terminus	NN	I-NP
O	1094	1096	to	to	TO	B-PP
O	1097	1100	the	the	DT	B-NP
B-Cellular_component	1101	1114	mitochondrial	mitochondrial	JJ	I-NP
I-Cellular_component	1115	1120	inner	inner	JJ	I-NP
I-Cellular_component	1121	1129	membrane	membrane	NN	I-NP
O	1129	1130	,	,	,	O
O	1131	1135	with	with	IN	B-PP
O	1136	1139	its	its	PRP$	B-NP
O	1140	1141	C	C	NN	I-NP
O	1142	1150	terminus	terminus	NN	I-NP
O	1151	1159	oriented	orient	VBN	B-VP
O	1160	1166	toward	toward	IN	B-PP
O	1167	1170	the	the	DT	B-NP
B-Immaterial_anatomical_entity	1171	1184	intermembrane	intermembrane	NN	I-NP
I-Immaterial_anatomical_entity	1185	1190	space	space	NN	I-NP
O	1190	1191	.	.	.	O

O	1192	1195	AIF	AIF	NN	B-NP
O	1196	1198	is	be	VBZ	B-VP
O	1199	1207	required	require	VBN	I-VP
O	1208	1211	for	for	IN	B-PP
O	1212	1221	oxidative	oxidative	JJ	B-NP
O	1222	1237	phosphorylation	phosphorylation	NN	I-NP
O	1238	1241	and	and	CC	B-PP
O	1242	1245	for	for	IN	B-PP
O	1246	1249	the	the	DT	B-NP
O	1250	1258	assembly	assembly	NN	I-NP
O	1259	1262	and	and	CC	O
O	1262	1263	/	/	SYM	B-NP
O	1263	1265	or	or	CC	O
O	1266	1279	stabilization	stabilization	NN	B-NP
O	1280	1282	of	of	IN	B-PP
O	1283	1294	respiratory	respiratory	JJ	B-NP
O	1295	1302	complex	complex	NN	I-NP
O	1303	1304	I	I	CD	I-NP
O	1304	1305	.	.	.	O
O	1305	1307	41	41	CD	B-NP
O	1308	1312	Upon	Upon	NNP	I-NP
O	1313	1322	induction	induction	NN	I-NP
O	1323	1325	of	of	IN	B-PP
O	1326	1335	apoptosis	apoptosis	NN	B-NP
O	1335	1336	,	,	,	O
O	1337	1340	AIF	AIF	NN	B-NP
O	1341	1343	is	be	VBZ	B-VP
O	1344	1351	cleaved	cleave	VBN	I-VP
O	1352	1355	and	and	CC	I-VP
O	1356	1364	released	release	VBN	I-VP
O	1365	1369	into	into	IN	B-PP
O	1370	1373	the	the	DT	B-NP
B-Organism_substance	1374	1381	cytosol	cytosol	NN	I-NP
O	1381	1382	,	,	,	O
O	1383	1388	where	where	WRB	B-ADVP
O	1389	1391	it	it	PRP	B-NP
O	1392	1404	translocates	translocate	VBZ	B-VP
O	1405	1407	to	to	TO	B-PP
O	1408	1411	the	the	DT	B-NP
B-Cellular_component	1412	1419	nucleus	nucleus	NN	I-NP
O	1420	1423	and	and	CC	O
O	1424	1432	mediates	mediate	VBZ	B-VP
B-Cellular_component	1433	1442	chromatin	chromatin	NN	B-NP
O	1443	1455	condensation	condensation	NN	I-NP
O	1456	1459	and	and	CC	O
O	1460	1465	large	large	JJ	B-NP
O	1465	1466	-	-	HYPH	I-NP
O	1466	1471	scale	scale	NN	I-NP
O	1472	1475	DNA	DNA	NN	I-NP
O	1476	1489	fragmentation	fragmentation	NN	I-NP
O	1489	1490	.	.	.	O
O	1490	1492	41	41	CD	B-NP
O	1493	1500	However	However	NNP	I-NP
O	1500	1501	,	,	,	O
O	1502	1506	this	this	DT	B-NP
O	1507	1511	well	well	RB	B-VP
O	1511	1512	-	-	HYPH	I-VP
O	1512	1517	known	know	VBN	I-VP
O	1518	1521	pro	pro	AFX	O
O	1521	1522	-	-	HYPH	O
O	1522	1531	apoptotic	apoptotic	JJ	B-NP
O	1532	1538	action	action	NN	I-NP
O	1539	1541	of	of	IN	B-PP
O	1542	1545	AIF	AIF	NN	B-NP
O	1546	1548	is	be	VBZ	B-VP
O	1549	1551	in	in	IN	B-PP
O	1552	1560	conflict	conflict	NN	B-NP
O	1561	1565	with	with	IN	B-PP
O	1566	1569	the	the	DT	B-NP
O	1570	1581	observation	observation	NN	I-NP
O	1582	1586	that	that	IN	B-SBAR
O	1587	1590	AIF	AIF	NN	B-NP
O	1591	1593	is	be	VBZ	B-VP
O	1594	1603	essential	essential	JJ	B-ADJP
O	1604	1607	for	for	IN	B-PP
O	1608	1611	the	the	DT	B-NP
O	1612	1623	maintenance	maintenance	NN	I-NP
O	1624	1626	of	of	IN	B-PP
O	1627	1633	normal	normal	JJ	B-NP
B-Organ	1634	1639	heart	heart	NN	I-NP
O	1640	1648	function	function	NN	I-NP
O	1649	1652	and	and	CC	O
O	1653	1656	its	its	PRP$	B-NP
O	1657	1669	inactivation	inactivation	NN	I-NP
O	1670	1677	results	result	VBZ	B-VP
O	1678	1680	in	in	IN	B-PP
O	1681	1688	dilated	dilate	VBN	B-NP
O	1689	1690	C	C	NNP	I-NP
O	1690	1691	.	.	.	I-NP
O	1691	1693	42	42	CD	I-NP
O	1694	1702	Moreover	Moreover	RB	B-ADVP
O	1702	1703	,	,	,	O
B-Cell	1704	1711	cardiac	cardiac	JJ	B-NP
I-Cell	1712	1720	myocytes	myocyte	NNS	I-NP
O	1721	1729	isolated	isolate	VBN	B-VP
O	1730	1734	from	from	IN	B-PP
O	1735	1736	a	a	DT	B-NP
O	1737	1742	mouse	mouse	NN	I-NP
O	1743	1748	model	model	NN	I-NP
O	1749	1753	with	with	IN	B-PP
O	1754	1756	80	80	CD	B-NP
O	1756	1757	%	%	NN	I-NP
O	1758	1767	reduction	reduction	NN	I-NP
O	1768	1770	in	in	IN	B-PP
O	1771	1774	AIF	AIF	NN	B-NP
O	1775	1781	levels	level	NNS	I-NP
O	1782	1792	manifested	manifest	VBD	B-VP
O	1793	1802	increased	increase	VBN	B-NP
B-Cell	1803	1807	cell	cell	NN	I-NP
O	1808	1813	death	death	NN	I-NP
O	1814	1821	induced	induce	VBN	B-VP
O	1822	1824	by	by	IN	B-PP
O	1825	1834	oxidative	oxidative	JJ	B-NP
O	1835	1841	stress	stress	NN	I-NP
O	1841	1842	,	,	,	O
O	1843	1846	and	and	CC	O
O	1847	1850	the	the	DT	B-NP
B-Organ	1851	1857	hearts	heart	NNS	I-NP
O	1858	1860	of	of	IN	B-PP
O	1861	1866	these	these	DT	B-NP
O	1867	1871	mice	mouse	NNS	I-NP
O	1872	1881	displayed	display	VBD	B-VP
O	1882	1890	enhanced	enhance	VBN	I-VP
O	1891	1899	ischemic	ischemic	JJ	B-NP
O	1900	1906	damage	damage	NN	I-NP
O	1907	1912	after	after	IN	B-PP
O	1913	1915	in	in	FW	B-NP
O	1916	1920	vivo	vivo	FW	I-NP
O	1921	1922	I	I	NN	I-NP
O	1922	1923	/	/	SYM	B-NP
O	1923	1924	R	R	NN	I-NP
O	1924	1925	.	.	.	B-NP
O	1925	1927	43	43	CD	I-NP
O	1928	1936	Although	Although	IN	B-SBAR
O	1937	1939	it	it	PRP	B-NP
O	1940	1943	has	have	VBZ	B-VP
O	1944	1948	been	be	VBN	I-VP
O	1949	1958	described	describe	VBN	I-VP
O	1959	1963	that	that	IN	B-SBAR
O	1964	1967	AIF	AIF	NN	B-NP
O	1968	1970	is	be	VBZ	B-VP
O	1971	1979	released	release	VBN	I-VP
O	1980	1984	from	from	IN	B-PP
B-Cellular_component	1985	1992	cardiac	cardiac	JJ	B-NP
I-Cellular_component	1993	2000	myocyte	myocyte	NN	I-NP
I-Cellular_component	2001	2013	mitochondria	mitochondrion	NNS	I-NP
O	2014	2020	during	during	IN	B-PP
O	2021	2022	I	I	NN	B-NP
O	2022	2023	/	/	SYM	B-NP
O	2023	2024	R	R	NN	I-NP
O	2024	2025	,	,	,	O
O	2026	2029	its	its	PRP$	B-NP
O	2030	2042	contribution	contribution	NN	I-NP
O	2043	2045	to	to	TO	B-PP
O	2046	2047	I	I	NN	B-NP
O	2047	2048	/	/	SYM	B-NP
O	2048	2049	R	R	NN	I-NP
O	2049	2050	-	-	HYPH	B-NP
O	2050	2057	induced	induce	VBN	I-NP
O	2058	2067	apoptosis	apoptosis	NN	I-NP
O	2068	2071	was	be	VBD	B-VP
O	2072	2082	discounted	discount	VBN	I-VP
O	2082	2083	.	.	.	O
O	2083	2085	38	38	CD	B-NP
O	2086	2093	However	However	RB	B-ADVP
O	2093	2094	,	,	,	O
O	2095	2098	AIF	AIF	NN	B-NP
O	2099	2102	has	have	VBZ	B-VP
O	2103	2107	been	be	VBN	I-VP
O	2108	2118	implicated	implicate	VBN	I-VP
O	2119	2121	in	in	IN	B-PP
B-Cell	2122	2129	cardiac	cardiac	JJ	B-NP
I-Cell	2130	2137	myocyte	myocyte	NN	I-NP
O	2138	2143	death	death	NN	I-NP
O	2144	2151	induced	induce	VBN	B-VP
O	2152	2154	by	by	IN	B-PP
O	2155	2164	oxidative	oxidative	JJ	B-NP
O	2165	2171	stress	stress	NN	I-NP
O	2172	2175	and	and	CC	I-NP
O	2176	2178	HF	HF	NN	I-NP
O	2178	2179	.	.	.	I-NP
O	2179	2181	44	44	CD	I-NP

O	2182	2194	Endonuclease	Endonuclease	NNP	B-NP
O	2195	2196	G	G	NNP	I-NP
O	2197	2198	(	(	(	O
O	2198	2202	Endo	Endo	NNP	B-NP
O	2203	2204	G	G	NNP	I-NP
O	2204	2205	)	)	)	O
O	2206	2208	is	be	VBZ	B-VP
O	2209	2210	a	a	DT	B-NP
B-Cellular_component	2211	2218	nuclear	nuclear	JJ	I-NP
O	2218	2219	-	-	HYPH	I-NP
O	2219	2226	encoded	encode	VBN	I-NP
O	2227	2239	endonuclease	endonuclease	NN	I-NP
O	2240	2249	localized	localize	VBD	B-VP
O	2250	2252	to	to	TO	B-PP
O	2253	2256	the	the	DT	B-NP
B-Immaterial_anatomical_entity	2257	2270	intermembrane	intermembrane	NN	I-NP
I-Immaterial_anatomical_entity	2271	2276	space	space	NN	I-NP
O	2277	2279	of	of	IN	B-PP
B-Cellular_component	2280	2292	mitochondria	mitochondrion	NNS	B-NP
O	2292	2293	.	.	.	O

O	2294	2296	In	In	IN	B-PP
B-Cell	2297	2304	cardiac	cardiac	JJ	B-NP
I-Cell	2305	2312	myocyte	myocyte	NN	I-NP
O	2313	2322	apoptosis	apoptosis	NN	I-NP
O	2322	2323	,	,	,	O
O	2324	2328	Endo	Endo	NNP	B-NP
O	2329	2330	G	G	NNP	I-NP
O	2331	2343	translocates	translocate	VBZ	B-VP
O	2344	2346	to	to	TO	B-PP
O	2347	2350	the	the	DT	B-NP
B-Cellular_component	2351	2358	nucleus	nucleus	NN	I-NP
O	2358	2359	,	,	,	O
O	2360	2365	where	where	WRB	B-ADVP
O	2366	2368	it	it	PRP	B-NP
O	2369	2376	cleaves	cleave	VBZ	B-VP
O	2377	2380	DNA	DNA	NN	B-NP
O	2380	2381	.	.	.	O

O	2382	2384	In	In	IN	B-PP
B-Organ	2385	2390	heart	heart	NN	B-NP
O	2391	2394	and	and	CC	O
O	2395	2403	cultured	culture	VBN	B-VP
B-Cell	2404	2411	cardiac	cardiac	JJ	B-NP
I-Cell	2412	2420	myocytes	myocyte	NNS	I-NP
O	2420	2421	,	,	,	O
O	2422	2426	Endo	Endo	NNP	B-NP
O	2427	2428	G	G	NNP	I-NP
O	2429	2432	has	have	VBZ	B-VP
O	2433	2434	a	a	DT	B-NP
O	2435	2439	role	role	NN	I-NP
O	2440	2442	in	in	IN	B-PP
O	2443	2444	I	I	NN	B-NP
O	2444	2445	/	/	SYM	B-NP
O	2445	2446	R	R	NN	I-NP
O	2446	2447	-	-	HYPH	B-NP
O	2447	2455	mediated	mediate	VBN	I-NP
B-Cell	2456	2460	cell	cell	NN	I-NP
O	2461	2466	death	death	NN	I-NP
O	2466	2467	.	.	.	O
O	2467	2469	38	38	CD	B-NP
O	2470	2480	Activation	Activation	NN	I-NP
O	2481	2483	of	of	IN	B-PP
O	2484	2487	the	the	DT	B-NP
O	2488	2497	intrinsic	intrinsic	JJ	I-NP
O	2498	2505	pathway	pathway	NN	I-NP
O	2506	2508	by	by	IN	B-PP
O	2509	2512	the	the	DT	B-NP
O	2513	2522	extrinsic	extrinsic	JJ	I-NP
O	2523	2532	apoptotic	apoptotic	JJ	I-NP
O	2533	2540	pathway	pathway	NN	I-NP
O	2541	2544	can	can	MD	B-VP
O	2545	2549	take	take	VB	I-VP
O	2550	2555	place	place	NN	B-NP
O	2556	2563	through	through	IN	B-PP
O	2564	2568	casp	casp	NN	B-NP
O	2568	2569	-	-	HYPH	B-NP
O	2569	2570	8	8	CD	I-NP
O	2570	2571	-	-	HYPH	I-NP
O	2571	2580	dependent	dependent	JJ	I-NP
O	2581	2589	cleavage	cleavage	NN	I-NP
O	2590	2592	of	of	IN	B-PP
O	2593	2597	BCL2	BCL2	NN	B-NP
O	2597	2598	-	-	HYPH	O
O	2598	2609	interacting	interact	VBG	B-VP
O	2610	2617	protein	protein	NN	B-NP
O	2618	2619	(	(	(	O
O	2619	2622	BID	BID	NN	B-NP
O	2622	2623	)	)	)	O
O	2624	2626	to	to	TO	B-PP
O	2627	2636	truncated	truncate	VBN	B-NP
O	2637	2640	BID	BID	NN	I-NP
O	2641	2642	(	(	(	O
O	2642	2643	t	t	NN	B-NP
O	2643	2644	-	-	HYPH	B-NP
O	2644	2647	BID	BID	NN	I-NP
O	2647	2648	)	)	)	O
O	2648	2649	.	.	.	O

O	2650	2653	The	The	DT	B-NP
O	2654	2655	C	C	NN	I-NP
O	2655	2656	-	-	HYPH	B-NP
O	2656	2664	terminal	terminal	JJ	I-NP
O	2665	2673	fragment	fragment	NN	I-NP
O	2674	2676	of	of	IN	B-PP
O	2677	2678	t	t	NN	B-NP
O	2678	2679	-	-	HYPH	B-NP
O	2679	2682	BID	BID	NN	I-NP
O	2683	2695	subsequently	subsequently	RB	B-ADVP
O	2696	2708	translocates	translocate	VBZ	B-VP
O	2709	2711	to	to	TO	B-PP
O	2712	2715	the	the	DT	B-NP
B-Cellular_component	2716	2729	mitochondrial	mitochondrial	JJ	I-NP
I-Cellular_component	2730	2735	outer	outer	JJ	I-NP
I-Cellular_component	2736	2744	membrane	membrane	NN	I-NP
O	2744	2745	,	,	,	O
O	2746	2751	where	where	WRB	B-ADVP
O	2752	2754	it	it	PRP	B-NP
O	2755	2765	presumably	presumably	RB	B-ADVP
O	2766	2775	activates	activate	VBZ	B-VP
O	2776	2779	the	the	DT	B-NP
O	2780	2789	intrinsic	intrinsic	JJ	I-NP
O	2790	2797	pathway	pathway	NN	I-NP
O	2797	2798	.	.	.	O

O	2799	2803	This	This	DT	B-NP
O	2804	2811	pathway	pathway	NN	I-NP
O	2812	2814	is	be	VBZ	B-VP
O	2815	2824	operative	operative	JJ	B-ADJP
O	2825	2827	in	in	IN	B-PP
O	2828	2831	the	the	DT	B-NP
B-Organ	2832	2837	heart	heart	NN	I-NP
O	2837	2838	.	.	.	O
O	2838	2839	1	1	CD	B-NP

